Abivax S.A.
obefazimod
ulcerative colitis
Resolved
8days ago
Phase 3 readout · Jun 29, 2026
What's at stake
Phase 3 trial results for obefazimod in ulcerative colitis are due Jun 29, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 14h ago
“Topline results of UC ABTECT Phase 3 maintenance trial - late Q2 2026”